Navigation Links
Common Medications Could Cause Physical Impairment in the Elderly
Date:5/3/2008

Drugs for acid reflux, urinary incontinence 'slow down' seniors, studies say

SATURDAY, May 3 (HealthDay News) -- Two new studies show that anticholinergics, a commonly prescribed group of drugs, may cause elderly people to "slow down" in their daily physical activities.

The two reports from researchers at Wake Forest University School of Medicine support findings released a few weeks ago that anticholinergic drugs -- which treat a variety of diseases and conditions, including acid reflux, Parkinson's disease and urinary incontinence -- may cause older people to lose their thinking skills more quickly than those who don't take the medicines.

Anticholinergic drugs work by stopping acetylcholine, a chemical that enhances communication between nerve cells in the brain, from binding to its receptors in nerve cells.

In the first Wake Forest study, older adults taking anticholinergics became more likely to walk more slowly and to need help in other daily activities.

"These results were true even in older adults who have normal memory and thinking abilities," study author Dr. Kaycee M. Sink said in a prepared statement. "For older adults taking a moderately anticholinergic medication, or two or more mildly anticholinergic medications, their function was similar to that of someone three to four years older."

Common anticholinergic medicines cited in the study included the blood pressure medication nifedipine (Adalat or Procardia), the stomach antacid ranitidine (Zantac) and the incontinence medication tolterodine (Detrol).

The findings, which involved more than 3,000 people, average age 78, were scheduled to be presented Saturday at the American Geriatrics Society annual meeting, in Washington, D.C.

In a separate Wake Forest study, published online in April in the Journal of the American Geriatrics Society, Sink found that older nursing home residents who took medicines for de
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Commonly used medications associated with impaired physical function in older adults
2. NHP Declares Its Quarterly Cash Dividends on Common Stock and Series B Preferred Stock
3. Pennsylvania Pharmacy Carve-out Poses Risks for Commonwealths Neediest Citizens and Taxpayers, National Organization Testifies
4. Delusions Common in Pediatric ICU
5. Daily aspirin may reduce risk of common type of breast cancer
6. Kidney Care Community Applauds National Taxpayers Unions Endorsement of Medicare Reforms to Extend Patient Private Health Insurance Coverage; Calls Proposal Common Sense Coverage Reform
7. Study shows common vitamin and other micronutrient supplements reduce risks of TB recurrence
8. Common Chemotherapy Drug Linked to Memory Problems
9. Obesity, inactivity as common among cancer survivors as rest of Canadians, study shows
10. Common Medications May Harm Memory in Older People
11. Almost Family Announces Pricing of 2,250,000 Common Shares
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Common Medications Could Cause Physical Impairment in the Elderly
Common Medications Could Cause Physical Impairment in the Elderly
Breaking Medicine News(10 mins):Health News:Save Flexible Spending Plans Applauds Amendment to Protect Flexible Spending Accounts 2Health News:Save Flexible Spending Plans Applauds Amendment to Protect Flexible Spending Accounts 3Health News:Are manometric findings different between the patients with erosive and nonerosive disease? 2Health News:Custom Health Plans Revamps Web site and Launches Blog to Help Consumers Find the Best Options for Affordable Health Insurance 2Health News:Selenium, Omega-3s May Stave Off Colorectal Cancer 2Health News:Selenium, Omega-3s May Stave Off Colorectal Cancer 3Health News:Selenium, Omega-3s May Stave Off Colorectal Cancer 4Health News:LodgeNet Interactive to Participate in UBS' 37th Annual Global Media and Communications Conference 2Health News:LodgeNet Interactive to Participate in UBS' 37th Annual Global Media and Communications Conference 3Health News:LodgeNet Interactive to Participate in UBS' 37th Annual Global Media and Communications Conference 4Health News:LodgeNet Interactive to Participate in UBS' 37th Annual Global Media and Communications Conference 5
Breaking Medicine Technology:Elsevier Selects BrainTrack Directory as Supplier of College Data 2Elsevier Selects BrainTrack Directory as Supplier of College Data 3Elsevier Selects BrainTrack Directory as Supplier of College Data 4AstraZeneca Medicare Part D Patient Assistance Program No Longer Requires Co-Pays 2Mylan Announces Settlement Agreement Related to Antidepressant Effexor XR(R) 2Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 1Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 2Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 3Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 4Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 5Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 6Alere Executives Present National Health Improvement Strategy to Congressional and Industry Leaders 47747 1Alere Executives Present National Health Improvement Strategy to Congressional and Industry Leaders 47747 2Alere Executives Present National Health Improvement Strategy to Congressional and Industry Leaders 47747 3Gene Network Sciences Announces Cancer Collaboration with University of Connecticut Health Centers Neag Comprehensive Cancer Center 47744 1Gene Network Sciences Announces Cancer Collaboration with University of Connecticut Health Centers Neag Comprehensive Cancer Center 47744 2Gene Network Sciences Announces Cancer Collaboration with University of Connecticut Health Centers Neag Comprehensive Cancer Center 47744 3